Literature DB >> 8079352

Applications of sensitivity analysis to a physiologically based pharmacokinetic model for carbon tetrachloride in rats.

M V Evans1, W D Crank, H M Yang, J E Simmons.   

Abstract

Physiologically based pharmacokinetic (PBPK) models developed from gas uptake experiments have been used to estimate metabolic parameters for volatile organic compounds. Due to the potential application of PBPK models to estimate metabolic bioactivation constants in humans, it is important to understand the complex nature of these models and the resulting estimates. Adult male F344 rats (165-205 g) were individually exposed to carbon tetrachloride (CCl4) in gas uptake systems. Three rats at each concentration were exposed for 6 hr to initial concentrations of 25, 100, 250, and 1000 ppm CCl4. Partition coefficient determinations were performed by the vial equilibration technique and used as model inputs. Computer optimizations with the means of each initial chamber concentration at each time point resulted in an estimate of Vmax of 0.11 mg/hr (Vmaxc = 0.37 mg/hr/kg) and Km of 1.3 mg/liter. To determine the effect of individual animal variation in Vmax, optimizations were also performed with the mean +/- SD, resulting in Vmax estimates of 0.09 and 0.12 mg/hr, respectively. Similar analysis resulted in Km estimates of 0.98 and 1.58 mg/liter. The results of the sensitivity analysis were concentration dependent for CCl4. These results show Vmax and Km to be most accurately detected at lower initial chamber concentrations. Results of the sensitivity analysis at the lowest concentration established the following model input hierarchy: blood to air partition > fat partition and fat volume fraction > slowly perfused partition, ventilation rate, cardiac output, fat blood flow percentage > liver blood flow percentage and slowly perfused blood flow percentage. Further sensitivity analysis determined Vmax and Km to be highly correlated when using gas uptake technology and point to the need to an independent estimate for either constant. In summary, the application of sensitivity analysis to PBPK modeling resulted in an increased understanding of factors governing the estimation of metabolic parameters.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8079352     DOI: 10.1006/taap.1994.1177

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  12 in total

1.  Sensitivity analysis of pharmacokinetic and pharmacodynamic systems: I. A structural approach to sensitivity analysis of physiologically based pharmacokinetic models.

Authors:  I A Nestorov
Journal:  J Pharmacokinet Biopharm       Date:  1999-12

Review 2.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Physiologically based pharmacokinetic modeling of a homologous series of barbiturates in the rat: a sensitivity analysis.

Authors:  I A Nestorov; L J Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1997-08

4.  A human physiologically-based model for glycyrrhzic acid, a compound subject to presystemic metabolism and enterohepatic cycling.

Authors:  B Ploeger; T Mensinga; A Sips; J Meulenbelt; J DeJongh
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

5.  Global optimization of the Michaelis-Menten parameters using physiologically-based pharmacokinetic (PBPK) modeling and chloroform vapor uptake data in F344 rats.

Authors:  Marina V Evans; Christopher R Eklund; David N Williams; Yusupha M Sey; Jane Ellen Simmons
Journal:  Inhal Toxicol       Date:  2020-04-02       Impact factor: 2.724

6.  Visualization-based analysis for a mixed-inhibition binary PBPK model: determination of inhibition mechanism.

Authors:  Kristin K Isaacs; Marina V Evans; Thomas R Harris
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-06       Impact factor: 2.745

7.  Pharmacokinetic modeling of arsenite uptake and metabolism in hepatocytes--mechanistic insights and implications for further experiments.

Authors:  Michael R Easterling; Miroslav Styblo; Marina V Evans; Elaina M Kenyon
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-06       Impact factor: 2.745

8.  Application of physiologically-based pharmacokinetic modeling to explore the role of kidney transporters in renal reabsorption of perfluorooctanoic acid in the rat.

Authors:  Rachel Rogers Worley; Jeffrey Fisher
Journal:  Toxicol Appl Pharmacol       Date:  2015-11-06       Impact factor: 4.219

9.  Physiologically Based Pharmacokinetic (PBPK) Modeling of Metabolic Pathways of Bromochloromethane in Rats.

Authors:  W S Cuello; T A T Janes; J M Jessee; M A Venecek; M E Sawyer; C R Eklund; M V Evans
Journal:  J Toxicol       Date:  2012-04-11

Review 10.  Neurotoxic and pharmacokinetic responses to trichloroethylene as a function of exposure scenario.

Authors:  W K Boyes; P J Bushnell; K M Crofton; M Evans; J E Simmons
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.